Upside Biotechnologies' Series A Round

Upside Biotechnologies raised a round of funding on March 21, 2017.

Upside is developing an advanced treatment for severe burns. The Upside product is a regenerative medicine solution to current shortcomings in the current treatment of severe burns patients. Upside wi…

Articles about Upside Biotechnologies' Series A Round: